DevicePMAs@therightstef:P970053_S009 JSONTXT

{"project":"PMA_MER","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25425"},{"id":"T2","span":{"begin":9,"end":12},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C64956"},{"id":"T3","span":{"begin":39,"end":44},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C16782"},{"id":"T4","span":{"begin":58,"end":64},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62103"},{"id":"T5","span":{"begin":87,"end":91},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43428"},{"id":"T6","span":{"begin":92,"end":95},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C37912"},{"id":"T7","span":{"begin":105,"end":114},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C15368"},{"id":"T8","span":{"begin":115,"end":119},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43428"},{"id":"T9","span":{"begin":120,"end":123},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C37912"},{"id":"T10","span":{"begin":137,"end":140},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C64956"},{"id":"T11","span":{"begin":141,"end":146},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C16782"},{"id":"T12","span":{"begin":192,"end":195},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C64956"},{"id":"T13","span":{"begin":200,"end":209},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157203"},{"id":"T14","span":{"begin":279,"end":285},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C64353"},{"id":"T15","span":{"begin":294,"end":301},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25718"},{"id":"T16","span":{"begin":368,"end":373},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63534"},{"id":"T17","span":{"begin":409,"end":419},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48793"},{"id":"T18","span":{"begin":474,"end":477},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25150"},{"id":"T19","span":{"begin":488,"end":491},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C37912"},{"id":"T20","span":{"begin":513,"end":523},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25356"},{"id":"T21","span":{"begin":524,"end":533},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C54072"},{"id":"T22","span":{"begin":566,"end":571},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25629"},{"id":"T23","span":{"begin":596,"end":602},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25446"},{"id":"T24","span":{"begin":615,"end":622},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C61421"}],"text":"Approval for the nidek ec-5000 excimer laser system. The device uses a 6.0 mm optical zone and a 9.0 mm treatment zone and is indicated for laser assisted in-situ keratomileusis (lasik): 1) for the reduction or elimination of hyperopia refractive errors from +0.5 to +5.0 d of sphere with or without astigmatic refractive errors from +0.5 to +2.0 d at the spectacle plane with manifest refraction spherical equivalent (mrse) of +5.0 d or less; 2) in patients 21 years of age or older; and 3) in patients with documented stability of manifest refraction over the prior year, demonstrated by a change in mrse not greater than +/- 0.50 diopter."}

{"project":"updated_tagging_age_PMA_annotations","denotations":[{"id":"T5","span":{"begin":462,"end":486},"obj":"age_range"},{"id":"T6","span":{"begin":462,"end":464},"obj":"age_start"},{"id":"T7","span":{"begin":465,"end":470},"obj":"age_start_unit"},{"id":"T8","span":{"begin":481,"end":486},"obj":"age_end"}],"text":"Approval for the nidek ec-5000 excimer laser system. The device uses a 6.0 mm optical zone and a 9.0 mm treatment zone and is indicated for laser assisted in-situ keratomileusis (lasik): 1) for the reduction or elimination of hyperopia refractive errors from +0.5 to +5.0 d of sphere with or without astigmatic refractive errors from +0.5 to +2.0 d at the spectacle plane with manifest refraction spherical equivalent (mrse) of +5.0 d or less; 2) in patients 21 years of age or older; and 3) in patients with documented stability of manifest refraction over the prior year, demonstrated by a change in mrse not greater than +/- 0.50 diopter."}

{"project":"consensus_PMA_Age_Indications","denotations":[{"id":"T5","span":{"begin":462,"end":486},"obj":"age_range"},{"id":"T6","span":{"begin":462,"end":464},"obj":"age_start"},{"id":"T7","span":{"begin":465,"end":470},"obj":"age_start_unit"},{"id":"T8","span":{"begin":481,"end":486},"obj":"age_end"}],"text":"Approval for the nidek ec-5000 excimer laser system. The device uses a 6.0 mm optical zone and a 9.0 mm treatment zone and is indicated for laser assisted in-situ keratomileusis (lasik): 1) for the reduction or elimination of hyperopia refractive errors from +0.5 to +5.0 d of sphere with or without astigmatic refractive errors from +0.5 to +2.0 d at the spectacle plane with manifest refraction spherical equivalent (mrse) of +5.0 d or less; 2) in patients 21 years of age or older; and 3) in patients with documented stability of manifest refraction over the prior year, demonstrated by a change in mrse not greater than +/- 0.50 diopter."}

{"project":"Age_blah","denotations":[{"id":"T1","span":{"begin":462,"end":464},"obj":"age_start"},{"id":"T2","span":{"begin":465,"end":470},"obj":"age_start_unit"},{"id":"T3","span":{"begin":481,"end":486},"obj":"age_end"},{"id":"T4","span":{"begin":462,"end":486},"obj":"age_range"}],"text":"Approval for the nidek ec-5000 excimer laser system. The device uses a 6.0 mm optical zone and a 9.0 mm treatment zone and is indicated for laser assisted in-situ keratomileusis (lasik): 1) for the reduction or elimination of hyperopia refractive errors from +0.5 to +5.0 d of sphere with or without astigmatic refractive errors from +0.5 to +2.0 d at the spectacle plane with manifest refraction spherical equivalent (mrse) of +5.0 d or less; 2) in patients 21 years of age or older; and 3) in patients with documented stability of manifest refraction over the prior year, demonstrated by a change in mrse not greater than +/- 0.50 diopter."}

{"project":"PMA_age_indications","denotations":[{"id":"T6","span":{"begin":462,"end":464},"obj":"age_start"},{"id":"T5","span":{"begin":462,"end":486},"obj":"age_range"},{"id":"T7","span":{"begin":465,"end":470},"obj":"age_start_unit"},{"id":"T8","span":{"begin":481,"end":486},"obj":"age_end"}],"text":"Approval for the nidek ec-5000 excimer laser system. The device uses a 6.0 mm optical zone and a 9.0 mm treatment zone and is indicated for laser assisted in-situ keratomileusis (lasik): 1) for the reduction or elimination of hyperopia refractive errors from +0.5 to +5.0 d of sphere with or without astigmatic refractive errors from +0.5 to +2.0 d at the spectacle plane with manifest refraction spherical equivalent (mrse) of +5.0 d or less; 2) in patients 21 years of age or older; and 3) in patients with documented stability of manifest refraction over the prior year, demonstrated by a change in mrse not greater than +/- 0.50 diopter."}